Ananda Ghosh
Stock Analyst at H.C. Wainwright
(4.74)
# 653
Out of 4,662 analysts
117
Total ratings
63.7%
Success rate
27.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRQR ProQR Therapeutics | Maintained: Buy | $12 | $2.22 | +440.54% | 10 | Aug 17, 2026 | |
| DYN Dyne Therapeutics | Maintained: Buy | $50 | $26.78 | +86.71% | 10 | Aug 17, 2026 | |
| ANNX Annexon | Reiterated: Buy | $14 | $5.50 | +154.55% | 9 | Aug 14, 2026 | |
| MAZE Maze Therapeutics | Maintained: Buy | $110 | $29.75 | +269.75% | 20 | Aug 12, 2026 | |
| PEPG PepGen | Reiterated: Buy | $20 | $3.05 | +555.74% | 13 | Aug 7, 2026 | |
| GPCR Structure Therapeutics | Maintained: Buy | $70 | $54.13 | +29.32% | 20 | Aug 7, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintained: Buy | $37 | $30.21 | +22.48% | 13 | Aug 5, 2026 | |
| STOK Stoke Therapeutics | Maintained: Buy | $50 | $33.03 | +51.38% | 11 | Aug 4, 2026 | |
| SKYE Skye Bioscience | Maintained: Buy | $20 | $0.3059 | +6,438.08% | 7 | May 21, 2026 | |
| IVA Inventiva | Maintained: Buy | $24 | $4.76 | +404.20% | 4 | Jan 28, 2026 |
ProQR Therapeutics
Aug 17, 2026
Maintained: Buy
Price Target: $12
Current: $2.22
Upside: +440.54%
Dyne Therapeutics
Aug 17, 2026
Maintained: Buy
Price Target: $50
Current: $26.78
Upside: +86.71%
Annexon
Aug 14, 2026
Reiterated: Buy
Price Target: $14
Current: $5.50
Upside: +154.55%
Maze Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $110
Current: $29.75
Upside: +269.75%
PepGen
Aug 7, 2026
Reiterated: Buy
Price Target: $20
Current: $3.05
Upside: +555.74%
Structure Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $70
Current: $54.13
Upside: +29.32%
ACADIA Pharmaceuticals
Aug 5, 2026
Maintained: Buy
Price Target: $37
Current: $30.21
Upside: +22.48%
Stoke Therapeutics
Aug 4, 2026
Maintained: Buy
Price Target: $50
Current: $33.03
Upside: +51.38%
Skye Bioscience
May 21, 2026
Maintained: Buy
Price Target: $20
Current: $0.3059
Upside: +6,438.08%
Inventiva
Jan 28, 2026
Maintained: Buy
Price Target: $24
Current: $4.76
Upside: +404.20%